World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
60
Citations
10886
World Ranking
12122
National Ranking
5189

Joseph L. Kuti publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Joseph L. Kuti sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 290 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Joseph L. Kuti D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Joseph L. Kuti sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 60 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Joseph L. Kuti is affiliated with Hartford Hospital in the United States and has made significant contributions in the fields of medicine, with a particular focus on pharmacology, molecular medicine, and epidemiology. Their research spans areas such as antibiotics pharmacokinetics and efficacy, antibiotic resistance in bacteria, pneumonia and respiratory infections, antibiotic use and resistance, cystic fibrosis research advances, pharmacological effects and toxicity studies, and infections and bacterial resistance.

Their publication record includes contributions to notable scientific journals. Frequent publication venues for Kuti include:

  • Open Forum Infectious Diseases
  • Journal of Antimicrobial Chemotherapy
  • Antimicrobial Agents and Chemotherapy
  • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  • International Journal of Antimicrobial Agents

Kuti has collaborated extensively with researchers such as David P. Nicolau, Andrew J Fratoni, Kristin E. Linder, Maxwell J. Lasko, and Aliaa Fouad.

Recent papers by Joseph L. Kuti include:

  • "A guide to therapeutic drug monitoring of β-lactam antibiotics," 2021, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  • "International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society of Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists," 2023, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  • "Pharmacodynamic Thresholds for Beta-Lactam Antibiotics: A Story of Mouse Versus Man," 2022, Frontiers in Pharmacology
  • "Lung penetration, bronchopulmonary pharmacokinetic/pharmacodynamic profile and safety of 3 g of ceftolozane/tazobactam administered to ventilated, critically ill patients with pneumonia," 2020, Journal of Antimicrobial Chemotherapy
  • "Pharmacokinetics and Pharmacodynamics of Ceftolozane/Tazobactam in Critically Ill Patients With Augmented Renal Clearance," 2021, International Journal of Antimicrobial Agents

Best Publications

  • Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

    Jason A Roberts;Jason A Roberts;Mohd H Abdul-Aziz;Jeffrey Lipman;Jeffrey Lipman;Johan W Mouton

  • Clinical Pharmacodynamics of Meropenem in Patients with Lower Respiratory Tract Infections

    Chonghua Li;Xiaoli Du;Joseph L. Kuti;David P. Nicolau

  • Use of Monte Carlo simulation to design an optimized pharmacodynamic dosing strategy for meropenem.

    Joseph L. Kuti;Prachi K. Dandekar;Charles H. Nightingale;David P. Nicolau

  • Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patients

    Chonghua Li;Joseph L. Kuti;Charles H. Nightingale;David P. Nicolau

  • Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study.

    Su Young Lee;Srividya Kotapati;Joseph L Kuti;Charles H Nightingale

  • Randomized, Open-Label, Comparative Study of Piperacillin-Tazobactam Administered by Continuous Infusion versus Intermittent Infusion for Treatment of Hospitalized Patients with Complicated Intra-Abdominal Infection

    William K. Lau;David Mercer;Kamal M. Itani;David P. Nicolau

  • Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital.

    Edward M. Grant;Joseph L. Kuti;David P. Nicolau;Charles Nightingale

  • Clinical Pharmacodynamics of Cefepime in Patients Infected with Pseudomonas aeruginosa

    Jared L. Crandon;Catharine C. Bulik;Joseph L. Kuti;David P. Nicolau

  • Optimizing antimicrobial pharmacodynamics: dosage strategies for meropenem

    Holly M. Mattoes;Joseph L. Kuti;George L. Drusano;David P. Nicolau

  • Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection.

    Chonghua Li;Joseph L. Kuti;Charles H. Nightingale;Debra L. Mansfield

  • Optimizing Pharmacodynamic Target Attainment Using the MYSTIC Antibiogram: Data Collected in North America in 2002

    Joseph L. Kuti;Charles H. Nightingale;David P. Nicolau

  • Optimising dosing strategies of antibacterials utilising pharmacodynamic principles: impact on the development of resistance.

    C Andrew DeRyke;Su Young Lee;Joseph L Kuti;David P Nicolau

  • Pulmonary Disposition of Tedizolid following Administration of Once-Daily Oral 200-Milligram Tedizolid Phosphate in Healthy Adult Volunteers

    Seth T. Housman;J. Samuel Pope;John Russomanno;Edward Salerno

  • Population Pharmacokinetics of High-Dose, Prolonged-Infusion Cefepime in Adult Critically Ill Patients with Ventilator-Associated Pneumonia

    Anthony M. Nicasio;Robert E. Ariano;Sheryl A. Zelenitsky;Aryun Kim

  • Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia

    Anthony M. Nicasio;Kathryn J. Eagye;David P. Nicolau;Eric Shore;Eric Shore

  • Comparison of Meropenem MICs and Susceptibilities for Carbapenemase-Producing Klebsiella pneumoniae Isolates by Various Testing Methods

    Catharine C. Bulik;Kathy A. Fauntleroy;Stephen G. Jenkins;Mayssa Abuali

  • Early Antibiotic Discontinuation in Patients With Clinically Suspected Ventilator-Associated Pneumonia and Negative Quantitative Bronchoscopy Cultures*

    Kirthana Raman;Michael D. Nailor;David P. Nicolau;Jaber Aslanzadeh

  • Pharmacodynamic Target Attainment of Six β-Lactams and Two Fluoroquinolones Against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella Species Collected from United States Intensive Care Units in 2004

    C. Andrew DeRyke;Joseph L. Kuti;David P. Nicolau

  • Optimal dosing of piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa infections: prolonged or continuous infusion?

    Aryun Kim;Christina A Sutherland;Joseph L Kuti;David P Nicolau

  • Prolonging β-lactam infusion: A review of the rationale and evidence, and guidance for implementation

    Shawn H. MacVane;Joseph L. Kuti;David P. Nicolau

Frequent Co-Authors

David P. Nicolau
David P. Nicolau Hartford Hospital
Richard Quintiliani
Richard Quintiliani Hartford Hospital
Cesar A. Arias
Cesar A. Arias The University of Texas Health Science Center at Houston
Charles H. Nightingale
Charles H. Nightingale University of Connecticut
Jann-Tay Wang
Jann-Tay Wang National Taiwan University
Michael J. Rybak
Michael J. Rybak Wayne State University
Jason A. Roberts
Jason A. Roberts University of Queensland
Jeffrey Lipman
Jeffrey Lipman University of Queensland
Antoni Torres
Antoni Torres University of Barcelona
George L. Drusano
George L. Drusano University of Florida

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry opens a variety of rewarding online degree and career pathways. For those interested in patient care and seeking advancement, the rn to bsn pathway offers a streamlined route for registered nurses to earn a Bachelor of Science in Nursing online, expanding clinical knowledge and job options.

If management roles in healthcare appeal to you, earning a fast online master's in healthcare management can help you move quickly into supervisory or administrative positions. These programs focus on leadership skills vital for hospital and healthcare facility management.

For those leaning toward mental health services, specialized advanced degrees such as pmhnp programs prepare graduates to become Psychiatric Mental Health Nurse Practitioners, a growing field in healthcare delivery.

Nutrition is another in-demand area. Completing the fastest nutrition degree online helps you qualify for roles in nutrition science, dietetics, or health coaching—ideal for combining biochemistry with practical patient support.

Best Scientists Citing Joseph L. Kuti

Trending Scientists

Recently Published Articles